Basic Information
REMD is a preclinical and clinical-stage biopharmaceutical company that utilizes cutting-edge biopharmaceutical technologies to develop novel, safe, effective, and affordable biomedicines for patients, targeting prevalent metabolic disorders and cancer-related diseases.
Rehmed Biopharma, Inc
California,United States of America
unclear
January 01, 2011
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios